|
|
||||||||
J Thorac Cardiovasc Surg 1995;110:89-98
© 1995 Mosby, Inc.
CARDIOPULMONARY BYPASS, |
Bad Nauheim, Germany
Supported by a grant from the Minna-James-Heineman Foundation, München, Germany.
Received for publication May 26, 1994. Accepted for publication Nov. 14, 1994. Address for reprints: Jutta Schaper, MD, PhD, Max-Planck-Institute, Department of Experimental Cardiology, Benekestrasse 2, D-61231 Bad Nauheim, Germany.
Abstract
Ischemia is known to produce damage to subcellular organelles, such as nuclei and mitochondria, in myocardial tissue. We tested the hypothesis that during myocardial ischemia various cytoskeletal and contractile proteins also undergo changes. We induced total global ischemia by incubation in buffer of tissue samples from six human left ventricles that were obtained from heart transplant recipients. Samples were removed from the incubation medium at different time intervals and investigated by immunohistochemistry using monoclonal antibodies against myosin, actin, tropomyosin, troponin T, myomesin, desmin, tubulin, and vinculin. The degree of ischemic injury was determined by electron microscopy. Ischemic cardiomyopathic human tissue showed disturbances of the localization pattern of myosin, actin, tropomyosin, and troponin T as early as 10 minutes after the onset of ischemia; this disruption was complete at 20 minutes. Tubulin also started changing at 10 minutes, but complete disruption was only evident after 120 minutes. Desmin and myomesin showed an intermediate response; changes began at 30 to 40 minutes, and disruption was complete at 90 to 120 minutes. Vinculin was most resistant to ischemia. Ultrastructurally, the tissue showed moderate reversible ischemic injury during the entire period of 180 minutes. Measuring the exposure time in seconds allowed quantitation of the intensity of the fluorescence. We reached the following conclusions: (1) Ischemia causes damage to the contractile proteins sooner than to the cytoskeleton and subcellular organelles. (2) Diseased human hearts are extremely susceptible to the effects of ischemia. These findings are important for the situation of induced cardiac arrest in heart operations and for preservation of donor hearts for transplantation. (J THORACCARDIOVASCSURG1995;110:89-98)
This article has been cited by other articles:
![]() |
X.-Y. Lu, L. Chen, X.-L. Cai, and H.-T. Yang Overexpression of heat shock protein 27 protects against ischaemia/reperfusion-induced cardiac dysfunction via stabilization of troponin I and T Cardiovasc Res, August 1, 2008; 79(3): 500 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C Gaze and P. O Collinson Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance Ann Clin Biochem, July 1, 2008; 45(4): 349 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Goers, S. Ramachandran, A. Aloush, E. Trulock, G. A. Patterson, and T. Mohanakumar De Novo Production of K-{alpha}1 Tubulin-Specific Antibodies: Role in Chronic Lung Allograft Rejection J. Immunol., April 1, 2008; 180(7): 4487 - 4494. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lu, C. Jun-xian, X. Rong-sheng, L. Jia, H. Ying, Z. Li-qun, and D. Ying-nan The effect of streptomycin on stretch-induced electrophysiological changes of isolated acute myocardial infarcted hearts in rats Europace, August 1, 2007; 9(8): 578 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Abramov, M. Abu-Tailakh, M. Frieger, A. Ganiel, D. Tuvbin, and A. Wolak Plasma Troponin Levels After Cardiac Surgery vs After Myocardial Infarction Asian Cardiovasc Thorac Ann, December 1, 2006; 14(6): 530 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Palmer, P. F. Klawitter, P. J. Reiser, and M. G. Angelos Degradation of rat cardiac troponin I during ischemia independent of reperfusion Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1269 - H1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Goto, H Takase, T Toriyama, T Sugiura, K Sato, R Ueda, and Y Dohi Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure Heart, November 1, 2003; 89(11): 1303 - 1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. de Jonge, D. F. van Wichen, M. E. I. Schipper, J. R. Lahpor, F. H. J. Gmelig-Meyling, E. O. Robles de Medina, and R. A. de Weger Left ventricular assist device in end-stage heart failure: persistence of structural myocyte damage after unloading: An immunohistochemical analysis of the contractile myofilaments J. Am. Coll. Cardiol., March 20, 2002; 39(6): 963 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Calaghan, J.-Y. Le Guennec, and E. White Modulation of Ca2+ Signaling by Microtubule Disruption in Rat Ventricular Myocytes and Its Dependence on the Ruptured Patch-Clamp Configuration Circ. Res., March 2, 2001; 88 (4): e32 - e37. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Cipolla, N. Lessov, W. M. Clark, and E. C. Haley Jr Postischemic Attenuation of Cerebral Artery Reactivity Is Increased in the Presence of Tissue Plasminogen Activator • Editorial Comment Stroke, April 1, 2000; 31(4): 940 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Rappaport Ischemia-reperfusion associated myocardial contractile dysfunction may depend on Ca2+-activated cytoskeleton protein degradation Cardiovasc Res, March 1, 2000; 45(4): 810 - 812. [Full Text] [PDF] |
||||
![]() |
C. Saunders and L. E. Limbird Microtubule-Dependent Regulation of alpha 2B Adrenergic Receptors in Polarized MDCKII Cells Requires the Third Intracellular Loop but Not G Protein Coupling Mol. Pharmacol., January 1, 2000; 57(1): 44 - 52. [Abstract] [Full Text] |
||||
![]() |
A. J. Liedtke and M. L. Lynch Alteration of gene expression for glycolytic enzymes in aerobic and ischemic myocardium Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1435 - H1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. McDonough, D. K. Arrell, and J. E. Van Eyk Troponin I Degradation and Covalent Complex Formation Accompanies Myocardial Ischemia/Reperfusion Injury Circ. Res., January 22, 1999; 84(1): 9 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kuhn-Regnier, E. Natour, S. Dhein, O. Dapunt, H. J. Geissler, K. LaRose, C. Gorg, and U. Mehlhorn Beta-blockade versus Buckberg blood-cardioplegia in coronary bypass operation Eur. J. Cardiothorac. Surg., January 1, 1999; 15(1): 67 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Bluhm, J. L. Martin, R. Mestril, and W. H. Dillmann Specific heat shock proteins protect microtubules during simulated ischemia in cardiac myocytes Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2243 - H2249. [Abstract] [Full Text] [PDF] |
||||
![]() |
M GALIÑANES In search of a reliable marker of tissue injury during heart surgery Heart, October 1, 1998; 80(4): 317 - 318. [Full Text] |
||||
![]() |
J. E. Van Eyk, F. Powers, W. Law, C. Larue, R. S. Hodges, and R. J. Solaro Breakdown and Release of Myofilament Proteins During Ischemia and Ischemia/Reperfusion in Rat Hearts : Identification of Degradation Products and Effects on the pCa-Force Relation Circ. Res., February 9, 1998; 82(2): 261 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Missov, C. Calzolari, and B. Pau Circulating Cardiac Troponin I in Severe Congestive Heart Failure Circulation, November 4, 1997; 96(9): 2953 - 2958. [Abstract] [Full Text] |
||||
![]() |
I. Birdi, G. D. Angelini, and A. J. Bryan Biochemical Markers of Myocardial Injury During Cardiac Operations Ann. Thorac. Surg., March 1, 1997; 63(3): 879 - 884. [Abstract] [Full Text] |
||||
![]() |
M. A. Sussman, S. F. Hamm-Alvarez, P. M. Vilalta, S. Welch, and L. Kedes Involvement of Phosphorylation in Doxorubicin-Mediated Myofibril Degeneration: An Immunofluorescence Microscopy Analysis Circ. Res., January 1, 1997; 80(1): 52 - 61. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |